European Pharmaceutical Contract Manufacturing Market Forecast 2018-2023

European pharmaceutical contract manufacturing market size, share, market intelligence, company profiles, market trends, growth, insider, strategy, research & analysis report, forecast 2018-2023

European pharmaceutical contract manufacturing market is growing significantly due to cost-effective production, increased inventory and so forth that are otherwise major concerns for the pharmaceutical manufacturers. In addition, rapid turnaround time to introduce new drugs to the market is also a critical concern for pharmaceutical companies. Therefore, contract manufacturing organizations are emerging as an effective alternative to pharmaceutical companies. The partnership with CDMO (contract development & manufacturing organization) enables pharmaceutical firms to reduce drug development cost and save time for further processes.

Moreover, the major factor supporting the growth of European pharmaceutical contract manufacturing market include soaring European pharmaceutical industry. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), production of pharmaceutical products in Europe has reached $257 billion in 2015 which was approximately 16.4% higher than the production in 2010. This represents the growing demand for pharmaceutical products in the region, which in turn is driving the demand for European CDMO to meet the increasing demand for pharmaceutical products and support in R&D activities. Additionally, significant pharmaceutical R&D spending by European economies, increasing demand for generic drugs and the presence of major players is further contributing towards the market growth. However, issues over quality control and shift towards Asia-Pacific countries such as India and China for pharmaceutical outsourcing are hindering the growth of European pharmaceutical contract manufacturing market. In addition, advances in drug discovery and increasing R&D investment by contract manufacturers are expected to create a significant opportunity for the market in the near future.

Browse full report at European Pharmaceutical Contract Manufacturing Market

Furthermore, European pharmaceutical contract manufacturing market is segmented on the basis of manufacturing process type, product type, route of administration and services. As per manufacturing process type, the market is segmented into sterile manufacturing and non-sterile manufacturing. Based on product type, the market is segmented into over-the-counter (OTC) drugs, active pharmaceutical ingredients, finished dosage formulations and others. Based on the route of administration, the market is segmented into oral administration, inhaled administration, parenteral administration, and others. Based on service, the market is segmented into manufacturing, non-clinical service, and R&D.

The report covers

• Comprehensive research methodology of European pharmaceutical contract manufacturing market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key                              recommendations.
• Analysis of regional regulations and other government policies impacting the European                              pharmaceutical contract manufacturing market.
• Insights about market determinants which are stimulating the European pharmaceutical contract                manufacturing market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.

For related reports please visit Manufacturing Industry